Inflammation and repeated infections in CGD: two sides of a coin

Area of Science:

• Immunology
• Genetics
• Cell Biology

Background:

• Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder affecting approximately 1 in 250,000 individuals.
• It stems from a defect in the phagocytic respiratory burst, a critical component of the innate immune system responsible for pathogen killing.
• This defect impairs the production of reactive oxygen species (ROS) by myeloid cells, including neutrophils and macrophages.

Purpose of the Study:

• To summarize the pathophysiology of Chronic Granulomatous Disease.
• To highlight the clinical manifestations and diagnostic challenges.
• To discuss current and potential therapeutic strategies for CGD patients.

Main Methods:

• Review of existing literature on CGD.
• Analysis of the molecular mechanisms underlying the respiratory burst defect.
• Synthesis of clinical data regarding infection patterns and inflammatory responses.

Main Results:

• CGD patients exhibit recurrent, severe infections (bacterial and fungal) and unexplained inflammation, often leading to granuloma formation.
• The deficiency in ROS production compromises the ability of phagocytes to eliminate ingested microbes.
• Organ dysfunction can occur due to chronic inflammation and infection, impacting various tissues.

Conclusions:

• Effective management of CGD necessitates prompt diagnosis and preventive strategies to mitigate infections.
• Hematopoietic stem cell transplantation is a potentially curative option for select CGD patients.
• Further research into novel therapeutic approaches is warranted to improve outcomes for individuals with CGD.